Pfizer-BioNTech 2nd Covid vaccine shows less side effects
US-based Pfizer and German biotech firm BioNTech announced positive results for the Phase 1 trial of their second Covid-19 vaccine candidate, revealing that the latest vaccine candidate has fewer side effects than their first.According to…